-
Posted on Sunday November 22nd, 2009 at 12:09 in alternative medicine, support, symptoms, massage, coping, ovarian cancer, national cancer institute, leo f. buscaglia, colling & associates, society for integrative oncology, touch caring & cancer, william collinge ph.d. mph
One of the most comforting forms of support you can give a person with cancer is the use of touch. Family caregivers can significantly reduce symptoms in cancer patients at home through use of simple touch and massage techniques. These findings were ...
-
Posted on Friday November 20th, 2009 at 16:06 in clinical trials, dna, colon cancer, discoveries, genetics, conferences, ovarian cancer, endometriosis, endometrial cancer, national cancer institute, hypercalcemia, venous thromboembolism
…[T]here are several PI3K signaling pathway targeting drugs in clinical development for use against ovarian cancer and solid tumors, including GDC-0941, BEZ235, SF1126, XL-147, XL-765, BGT226, and PX-866. The results of two recent medical stu...
-
Posted on Saturday November 14th, 2009 at 20:31 in advocacy, fda, woody allen, cancer research, u.s. house of representatives, federal legislation, the west wing, department of defense, aaron sorkin, ovarian cancer research, senator robert menendez, centers for medicare & medicaid services
Responding to a threat of a funding reduction to the Department of Defense’s Ovarian Cancer Research Program, during the last week of October the Ovarian Cancer National Alliance urged advocates to contact their Members of Congress to appeal to the...
-
Posted on Thursday November 12th, 2009 at 00:32 in clinical trials, nih, cancer research, ovarian cancer, national institutes of health, national registry, clinicaltrials.gov, ctsa, ncrr, barbara alving m.d., clinical & translational science awards, ctsa consortium
Individuals who want to participate in research studies can connect online with researchers nationwide through the first disease-neutral, volunteer recruitment registry. ResearchMatch.org is a not-for-profit secure Web site, designed to provide peo...
-
Posted on Wednesday November 11th, 2009 at 18:45 in chemotherapy, discoveries, harvard medical school, acute lymphoblastic leukemia, ucla, yes, ovarian cancer, mayo clinic, lyn, upa, british journal of cancer, paclitaxel
The drug dasatinib (Sprycel®), approved for use by the U.S. Food and Drug Administration in patients with specific types of leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, say UCLA...
-
Posted on Wednesday November 4th, 2009 at 14:39 in chemotherapy, ovarian cancer, endometrial cancer, clinical trial results, novel therapies, pipeline drugs, american society of clinical oncology, biological therapies, doxorubicin, gynecologic cancer intergroup, aeterna zentaris, recist criteria
Preliminary Phase II clinical study evaluation shows that primary efficacy endpoint has been met for patients with advanced-stage, platinum-resistant, taxane-pretreated ovarian cancer who were treated with the targeted therapy AEZS-108. Æterna Zen...
Very informative blog. My mother had ovarian cancer. I will definitely continue to visit your blog.
Posted: August 26th, 2009 | More Reviews From givergirl12 | Report This Comment